MediFind
Condition

Epilepsy with Myoclonic-Atonic Seizures

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Myoclonic and/or Absence Seizures
  • Journal: Seizure
  • Treatment Used: Perampanel
  • Number of Patients: 163
  • Published —
This study investigated the use of perampanel to reduce seizures in patients with myoclonic and/or absence seizures.
Latest Advance
Study
  • Condition: COVID-19 in persons with epilepsy (Coronavirus)
  • Journal: Epilepsy research
  • Treatment Used: Chloroquine or hydroxychloroquine therapy
  • Number of Patients: 746
  • Published —
The study researched the use of chloroquine or hydroxychloroquine therapy for treating COVID-19 in persons with epilepsy (Coronavirus).
Latest Advance
Study
  • Condition: Epilepsy
  • Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
  • Treatment Used: Antiepileptic Therapy
  • Number of Patients: 103
  • Published —
This study evaluated the effectiveness of antiepileptic therapy (treatment with agents used in the treatment of epileptic seizures) of epileptic syndromes associated with myoclonic seizures (brief, shock-like jerks of a muscle or a group of muscles).
Latest Advance
Study
  • Condition: Drug-Resistant Focal Epilepsy
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Stiripentol
  • Number of Patients: 32
  • Published —
This study investigated the use of stiripentol to treat patients with drug-resistant focal epilepsy.
Latest Advance
Study
  • Condition: Lennox-Gastaut Syndrome and Dravet Syndrome
  • Journal: Epilepsia
  • Treatment Used: Cannabidiol Effectiveness Relative to Concomitant Clobazam
  • Number of Patients: 714
  • Published —
The purpose of the study was to evaluate the potential impact of concomitant clobazam use on the effectiveness of cannabidiol treatment in patients with Dravet syndrome and Lennox-Gastaut syndrome.
Latest Advance
Study
  • Condition: Neonatal Seizures
  • Journal: Pediatrics
  • Treatment Used: Levetiracetam or Phenobarbital
  • Number of Patients: 30
  • Published —
This study compared the clinical outcome of using levetiracetam or phenobarbital to treat patients with neonatal seizures.
Latest Advance
Study
  • Condition: Dravet Syndrome (DS)
  • Journal: Journal of neural engineering
  • Treatment Used: Vagus Nerve Stimulation (VNS)
  • Number of Patients: 20
  • Published —
This study investigated the effectiveness of vagus nerve stimulation (VNS) in patients with Dravet syndrome (severe epilepsy; DS).
Latest Advance
Study
  • Condition: Nonepileptic Myoclonus in Angelman Syndrome
  • Journal: Brain & development
  • Treatment Used: Perampanel
  • Number of Patients: 4
  • Published —
This study tested the effectiveness of perampanel for nonepileptic myoclonus in patients with Angelman syndrome.
Latest Advance
Study
  • Condition: Juvenile Myoclonic Epilepsy
  • Journal: Anales del sistema sanitario de Navarra
  • Treatment Used: Antiepileptic Drugs
  • Number of Patients: 20
  • Published —
The study researched the effects of stopping antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Latest Advance
Study
  • Condition: Convulsive Seizure Frequency in Dravet Syndrome
  • Journal: JAMA neurology
  • Treatment Used: Adjunctive Oral Cannabidiol vs Placebo
  • Number of Patients: 199
  • Published —
This study evaluated the safety and effectiveness of a pharmaceutical formulation of cannabidiol, 10 and 20 mg/kg/d, versus placebo for adjunctive treatment of convulsive seizures in patients with Dravet syndrome.
Latest Advance
Study
  • Condition: Dravet Syndrome
  • Journal: CNS drugs
  • Treatment Used: Cannabidiol (CBD)
  • Number of Patients: 359
  • Published —
In this review of the literature, researchers evaluated the effects of cannabidiol (CBD) on the seizures of persons with Dravet syndrome.
Latest Advance
Study
  • Condition: Pediatric Epilepsy
  • Journal: Neurology
  • Treatment Used: Surgery
  • Number of Patients: 0
  • Published —
The study researched the outcomes of surgery for pediatric epilepsy.